Explore peer-reviewed studies on antimicrobial resistance, sterilization protocols, and outbreak management
Explore how guselkumab, a targeted IL-23 inhibitor, is transforming treatment for moderate-to-severe plaque psoriasis through precision science and clinical evidence.